1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Small Research Grants for Analyses of Gabriella Miller Kids First Pediatric Research Data (R03 Clinical Trial Not Allowed) PAR-25-109 is sponsored by National Institutes of Health (NIH) - Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institute of Dental and Craniofacial Research (NIDCR), National Cancer Institute (NCI). Small Research Grants for Analyses of Gabriella Miller Kids First Pediatric Research Data (R03 Clinical Trial Not Allowed) PAR-25-109 is sponsored by National Institutes of Health (NIH) - Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Na…
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
202405 Small Research Grants for Analyses of Gabriella Miller Kids First Pediatric Research Data | NICHD - Eunice Kennedy Shriver National Institute of Child Health and Human Development 202405 Small Research Grants for Analyses of Gabriella Miller Kids First Pediatric Research Data Program seeks Council approval for the Simplified Review Framework Reissue for PAR-23-075 called “Small Research Grants for Analyses of Gabriella Miller Kids First Pediatric Research Data”.
NICHD, with participation from NCI, and NIDCR is supporting this NOFO. Kids First is a Common Fund program administered by NICHD, NHLBI, NCI,NHGRI. The program aims to accelerate research with shared data across pediatric conditions.
Data achievements include 33 studies released with over 27,000 genomes available, representing structural birth defects and childhood cancer patients and families. Nearly 700 data access requests have been approved for secondary use of the data. The program is also collaborating with multiple NIH data science resources.
Both birth defects and cancer are leading causes of death in childhood. It makes sense to study these conditions together since shared genomic variants and signaling pathways have been identified and a child born with a birth defect faces a higher risk of also having cancer.
This NOFO is intended to engage the expertise of the broader research community in projects that further increase the value of the data generated by Kids First; for example, by increasing the depth of phenotypic and clinical data available, developing new analysis tools, or providing additional analysis and annotation of Kids First data sets. Developmental Biology and Congenital Anomalies Branch (DBCAB) Back to Concept Review by Council
According to the current listing, eligibility includes: Investigators proposing analyses of Gabriella Miller Kids First Pediatric Research Data. (Clinical Trial Not Allowed). Confirm the full requirements in the official notice before applying.
Small Research Grants for Analyses of Gabriella Miller Kids First Pediatric Research Data (R03 Clinical Trial Not Allowed) PAR-25-109 is funded by National Institutes of Health (NIH) - Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institute of Dental and Craniofacial Research (NIDCR), National Cancer Institute (NCI). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
NICHD's FY2026 funding strategy applies an automatic 14 percent reduction to every new R01 below the peer-review recommended level, eliminates inflationary increases on future-year commitments, and abandons a fixed payline entirely in favor of priority-driven discretion. The structural implications for child health investigators.
Read articleThe Health and Extreme Weather highlighted topic went live September 1, 2026 with eleven awarding institutes and expires May 1, 2028. There is no set-aside, no separate deadline, and no review criteria — which makes the institute-by-institute language the only real signal, and it is not uniform.
Read articleThe NOURISH Autoimmunity Digital Health Challenge runs three phases to August 2028: 10 winners at $20,000, then 5 at $30,000, then 3 at $100,000. It is a prize competition, not a grant — no indirect costs, no cost reimbursement, and a rule that quietly disqualifies the obvious applicant.
Read article